UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Membrane disruption, but not metabolic rewiring, is the key mechanism of anticancer-action of FASN-inhibitors: a multi-omics analysis in ovarian cancer

Scientific reports, 2020-09, Vol.10 (1), p.14877-14877, Article 14877

2020

Volltextzugriff (PDF)

The Pharmacological or Genetic Blockade of Endogenous De Novo Fatty Acid Synthesis Does Not Increase the Uptake of Exogenous Lipids in Ovarian Cancer Cells

Frontiers in oncology, 2021-04, Vol.11, p.610885-610885

2021

Volltextzugriff (PDF)

Distribution of PD-L1, TROP2 and HER2- “lowness” in early triple-negative breast cancer: an opportunity for treatment de-escalation

Clinical & translational oncology, 2024-05, Vol.26 (5), p.1273-1279

2024

Volltextzugriff (PDF)

n-3 Fatty acids, cancer and cachexia: a systematic review of the literature

British journal of nutrition, 2007-05, Vol.97 (5), p.823-831

2007

Volltextzugriff (PDF)

Pain in Long-Term Cancer Survivors: Prevalence and Impact in a Cohort Composed Mostly of Breast Cancer Survivors

Cancers, 2024-04, Vol.16 (8), p.1581

2024

Volltextzugriff (PDF)

New Synthetic Inhibitors of Fatty Acid Synthase with Anticancer Activity

Journal of medicinal chemistry, 2012-06, Vol.55 (11), p.5013-5023

2012

Volltextzugriff (PDF)

Epigenetic Regulation of Gfi1 in Endocrine-Related Cancers: a Role Regulating Tumor Growth

International journal of molecular sciences, 2020-06, Vol.21 (13), p.4687

2020

Volltextzugriff (PDF)

Predictors of unknown cancer in patients with ischemic stroke

Journal of neuro-oncology, 2018-05, Vol.137 (3), p.551-557

2018

Volltextzugriff (PDF)

Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells

International journal of cancer, 2015-05, Vol.136 (9), p.2078-2090

2015

Volltextzugriff (PDF)

Multi-level suppression of receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for their efficacy against ovarian cancer cells

Oncotarget, 2017-02, Vol.8 (7), p.11600-11613

2017

Volltextzugriff (PDF)

Tumor P70S6K hyperactivation is inversely associated with tumor-infiltrating lymphocytes in triple-negative breast cancer

Clinical & translational oncology, 2023-04, Vol.25 (4), p.1124-1131

2023

Volltextzugriff (PDF)

Effectiveness, Toxicity, and Survival Predictors of Regorafenib in Metastatic Colorectal Cancer: A Multicenter Study of Routinely Collected Data

Oncology (Williston Park, N.Y.), 2022-12, Vol.36 (12), p.732-738

2022

Volltextzugriff (PDF)

Nivolumab-induced thyroid dysfunction in patients with lung cancer

Endocrinologia, diabetes y nutricion, 2019-01, Vol.66 (1), p.26-34

2019

Volltextzugriff (PDF)

CCR5 expression influences the progression of human breast cancer in a p53-dependent manner

The Journal of experimental medicine, 2003-11, Vol.198 (9), p.1381-1389

2003

Volltextzugriff (PDF)

Critically short telomeres and toxicity of chemotherapy in early breast cancer

Oncotarget, 2017-03, Vol.8 (13), p.21472-21482

2017

Volltextzugriff (PDF)

Natural Polyphenols and their Synthetic Analogs as Emerging Anticancer Agents

Current drug targets, 2017-01, Vol.18 (2), p.147-159

2017

Volltextzugriff (PDF)

Usefulness of the PERFORM questionnaire to measure fatigue in cancer patients with anemia: a prospective, observational study

Supportive care in cancer, 2013-11, Vol.21 (11), p.3039-3049

2013

Volltextzugriff (PDF)

When should we order a next generation sequencing test in a patient with cancer?

EClinicalMedicine, 2020-08, Vol.25, p.100487-100487, Article 100487

2020

Volltextzugriff (PDF)

FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1

Breast cancer research : BCR, 2021-02, Vol.23 (1), p.21-16, Article 21

2021

Volltextzugriff (PDF)

Essentiality of fatty acid synthase in the 2D to anchorage-independent growth transition in transforming cells

Nature communications, 2019-11, Vol.10 (1), p.5011-18, Article 5011

2019

Volltextzugriff (PDF)

Psychometric properties of the Perform Questionnaire: a brief scale for assessing patient perceptions of fatigue in cancer

Supportive care in cancer, 2011-05, Vol.19 (5), p.657-666

2011

Volltextzugriff (PDF)

EGF prevents the neuroendocrine differentiation of LNCaP cells induced by serum deprivation: the modulator role of PI3K/Akt

Neoplasia (New York, N.Y.), 2007-08, Vol.9 (8), p.614-624

2007

Volltextzugriff (PDF)

Complications of intramuscular metastasis in a patient with lung cancer

Medicina clinica, 2011-03, Vol.136 (6), p.273

2011

Volltextzugriff (PDF)

Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial

Breast cancer research : BCR, 2020-11, Vol.22 (1), p.124-124, Article 124

2020

Volltextzugriff (PDF)

Nintedanib plus letrozole in early breast cancer: a phase 0/I pharmacodynamic, pharmacokinetic, and safety clinical trial of combined FGFR1 and aromatase inhibition

Breast cancer research : BCR, 2019-05, Vol.21 (1), p.69-14, Article 69

2019

Volltextzugriff (PDF)

1 – 25 von 346

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(303)
Mit Volltextzugriff
(301)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Membrane disruption, but not metabolic rewiring, is the key mechanism of anticancer-action of FASN-inhibitors: a multi-omics analysis in ovarian cancer

The Pharmacological or Genetic Blockade of Endogenous De Novo Fatty Acid Synthesis Does Not Increase the Uptake of Exogenous Lipids in Ovarian Cancer Cells

Distribution of PD-L1, TROP2 and HER2- “lowness” in early triple-negative breast cancer: an opportunity for treatment de-escalation

n-3 Fatty acids, cancer and cachexia: a systematic review of the literature

Pain in Long-Term Cancer Survivors: Prevalence and Impact in a Cohort Composed Mostly of Breast Cancer Survivors

New Synthetic Inhibitors of Fatty Acid Synthase with Anticancer Activity

Epigenetic Regulation of Gfi1 in Endocrine-Related Cancers: a Role Regulating Tumor Growth

Predictors of unknown cancer in patients with ischemic stroke

Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells

Multi-level suppression of receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for their efficacy against ovarian cancer cells

Tumor P70S6K hyperactivation is inversely associated with tumor-infiltrating lymphocytes in triple-negative breast cancer

Effectiveness, Toxicity, and Survival Predictors of Regorafenib in Metastatic Colorectal Cancer: A Multicenter Study of Routinely Collected Data

Nivolumab-induced thyroid dysfunction in patients with lung cancer

CCR5 expression influences the progression of human breast cancer in a p53-dependent manner

Critically short telomeres and toxicity of chemotherapy in early breast cancer

Natural Polyphenols and their Synthetic Analogs as Emerging Anticancer Agents

Usefulness of the PERFORM questionnaire to measure fatigue in cancer patients with anemia: a prospective, observational study

When should we order a next generation sequencing test in a patient with cancer?

FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1

Essentiality of fatty acid synthase in the 2D to anchorage-independent growth transition in transforming cells

Psychometric properties of the Perform Questionnaire: a brief scale for assessing patient perceptions of fatigue in cancer

EGF prevents the neuroendocrine differentiation of LNCaP cells induced by serum deprivation: the modulator role of PI3K/Akt

Complications of intramuscular metastasis in a patient with lung cancer

Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial

Nintedanib plus letrozole in early breast cancer: a phase 0/I pharmacodynamic, pharmacokinetic, and safety clinical trial of combined FGFR1 and aromatase inhibition

Suchergebnisse filtern